Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a


Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului



Yüklə 4,39 Mb.
səhifə370/381
tarix07.01.2022
ölçüsü4,39 Mb.
#80899
1   ...   366   367   368   369   370   371   372   373   ...   381
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L04AA01 CICLOSPORINUM CAPS. MOI 100 mg

EQUORAL(R) 100 mg 100 mg IVAX - PHARMACEUTICALS

S.R.O.
L04AA01 CICLOSPORINUM SOL. ORALA 100 mg/ml

EQUORAL(R) 100 mg/ml IVAX - PHARMACEUTICALS

S.R.O.


SANDIMMUN NEORAL(R) 100 mg/ml NOVARTIS PHARMA GMBH
L04AA01 CICLOSPORINUM CAPS. MOI 25 mg

CICLORAL(R) HEXAL(R) 25 mg 25 mg HEXAL AG

EQUORAL(R) 25 mg 25 mg IVAX - PHARMACEUTICALS

S.R.O.


SANDIMMUN NEORAL(R) 25 mg NOVARTIS PHARMA GMBH
L04AA01 CICLOSPORINUM CAPS. MOI 50 mg

CICLORAL(R) HEXAL 50 mg 50 mg HEXAL AG

EQUORAL(R) 50 mg 50 mg IVAX - PHARMACEUTICALS

S.R.O.


SANDIMMUN NEORAL(R) 50 mg NOVARTIS PHARMA GMBH

________________________________________________________________________________


______________________________________________________________________________

| 1031 |L04AA05| TACROLIMUSUM** | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Terapie de menţinere consecutivă iniţierii şi


Yüklə 4,39 Mb.

Dostları ilə paylaş:
1   ...   366   367   368   369   370   371   372   373   ...   381




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©muhaz.org 2024
rəhbərliyinə müraciət

gir | qeydiyyatdan keç
    Ana səhifə


yükləyin